Pfizer Picking Up FoldRx in Latest Rare Disease Buyout

Just days after Sanofi-Aventis SA's official bid for Genzyme Corp., big pharma's pursuit of orphan drugs continued with Pfizer Inc.'s plan to buy out privately held FoldRx Pharmaceuticals Inc. for rights to a drug for rare neurodegenerative disease transthyretin amyloid polyneuropathy (ATTR-PN).

Drug Companies Hunt for Alternatives to Steroids

Drug makers are trying to develop medicines that possess the muscle-building ability of testosterone without its side effects.

Doctors seek to slow loss of muscle tone among aging

Why muscles wither with age is captivating a growing number of scientists and others.

Steroids ban must be for life

The benefits of using steroids can last a lifetime, according to a recent study.

Smoking marijuana helps reduce pain, trial shows

Researchers in Montreal have completed what they say is the first placebo-controlled clinical trial to show that smoking pot really helps to relieve pain.

Blogsphere: Technorati Feedster Bloglines
Bookmark: Del.icio.us Spurl Furl Simpy Blink Digg